SelectedWorks - Jennifer N. Eichmeyer

Contact

Selected Works of Jennifer N. Eichmeyer

Clinical Assistant Professor, School of Allied Health and Program Director, Genetic Counseling Program

Jennifer N. Eichmeyer started at Boise State University in 2017 and is currently the Program Director for the Genetic Counseling Program within the School of Allied Health Sciences. She earned her M.S. in Genetic Counseling from the University of Texas and a B.S. in Genetics from Iowa State Unviersity. Ms. Eichmeyer’s profession experience also includes working as a Genetic Counselor for the Genetic Support Foundation and as a Network Genetic Couselor for PWN Health, LLC. She is currently a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC), Pediatric Laboratory Utilization Guidance Services (PLUGS), and the Idaho Society of Clinical Oncology (ISCO) to name a few.

Works
About

×

About Jennifer N. Eichmeyer

Jennifer N. Eichmeyer started at Boise State University in 2017 and is currently the Program Director for the Genetic Counseling Program within the School of Allied Health Sciences. She earned her M.S. in Genetic Counseling from the University of Texas and a B.S. in Genetics from Iowa State Unviersity. Ms. Eichmeyer’s profession experience also includes working as a Genetic Counselor for the Genetic Support Foundation and as a Network Genetic Couselor for PWN Health, LLC. She is currently a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC), Pediatric Laboratory Utilization Guidance Services (PLUGS), and the Idaho Society of Clinical Oncology (ISCO) to name a few.

Peer-Reviewed Articles (14)

Assessing Burnout and Well-Being in Higher Education Health Science Faculty (Kristen McHenry, Megan Koster, Gen Ludwig, et al.) OBM Integrative and Complementary Medicine (2023)

This study aimed to examine and compare the extent of burnout among health science faculty at a higher education institution and their self-reported perception of well-being during the COVID-19 pandemic. The design of the study ...

Facing the Challenge of Genetic Counselors' Need for Rapid Continuing Education About Genomic Technologies (Kelly D. Farwell Hagman, Devon Lamb Thrush, Samantha Freeze, et al.) Journal of Genetic Counseling (2020)

The last couple of decades have seen the rapid advancement of genomic technologies (GT) and their equally rapid adoption into clinical testing. Regardless of specialty, all genetic counselors are unified by the fundamental goal to ...

PARC Report: A Perspective on the State of Clinical Pharmacogenomics Testing (Jennifer Eichmeyer) Pharmacogenomics (2020)

In this Perspective, the authors discuss the state of pharmacogenomics testing addressing a number of advances, challenges and barriers, including legal ramifications, changes to the regulatory landscape, coverage of testing and the implications of direct-to-consumer ...

Patient Care Situations Benefiting from Pharmacogenomic Testing (Rachel A. Mills, Jennifer N. Eichmeyer, Leah M. Williams, et al.) Current Genetic Medicine Reports (2018)

Purpose of Review Pharmacogenomics is an evolving area in precision medicine that aims to identify patients who have variable drug response, detect those at risk for developing adverse events, and guide drug dosing. Guidelines for ...

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting (Jennifer N. Eichmeyer) CTS: Clinical and Translational Science (2017)

Genotype is increasingly recognized as an important factor influencing the likelihood for drug effectiveness or risk for adverse events. Genetic information is now included in US Food and Drug Administration-approved labeling for over 130 drugs, ...

Delivering Pharmacogenetic Testing in the Community Setting (Mark Wagner, Jennifer Eichmeyer, Paul G. Montgomery, et al.) Oncology Issues (2016)

The ability to individualize medication therapy for cancer patients has significantly advanced in recent years and continues to expand into new areas of practice. One of these areas is pharmacogenetic testing, which evaluates inherited genetic ...

Identifying Candidate Genes for 2p15p16.1 Microdeletion Syndrome Using Clinical, Genomic, and Functional Analysis (Jennifer N. Eichmeyer) JCI Insight (2016)

The 2p15p16.1 microdeletion syndrome has a core phenotype consisting of intellectual disability, microcephaly, hypotonia, delayed growth, common craniofacial features, and digital anomalies. So far, more than 20 cases of 2p15p16.1 microdeletion syndrome have been reported ...

The Value of a Genetic Counselor: Improving Identification of Cancer Genetic Counseling Patients with Chart Review (Jennifer N. Eichmeyer, Christa Burnham, Patty Sproat, et al.) Journal of Genetic Counseling (2014)

Advances in genetics are changing cancer care and requiring institutions to maximize the unique skills of genetics professionals. The identification of genetic syndromes is vital for prevention and management of families with high cancer risks. ...

The Value of a Genetic Counselor: Improving Identification of Cancer Genetic Counseling Patients with Chart Review (Jennifer N. Eichmeyer, Christa Burnham, Patty Sproat, et al.) Journal of Genetic Counseling (2014)

Advances in genetics are changing cancer care and requiring institutions to maximize the unique skills of genetics professionals. The identification of genetic syndromes is vital for prevention and management of families with high cancer risks. ...

Improving Access to Oncology Genetic Counseling (Jennifer N. Eichmeyer) Oncology Issues (2014)

While only 5 to 10 percent of cancer diagnoses are associated with a hereditary syndrome, many of these syndromes have an alarmingly high lifetime risk of cancer—approaching 80 to 100 percent, with development of disease ...

Variant ATRX Syndrome with Dysfunction of ATRX and MAGT1 Genes (Ying Qiao, Kajari Mondal, Valentina Trapani, et al.) Human Mutation: Variation, Informatics, and Disease (2014)

A 0.8kb intronic duplication in MAGT1 and a single base pair deletion in the last exon of ATRX were identified using a chromosome X-specific microarray and exome sequencing in a family with five males demonstrating intellectual disability (ID) and ...

The NCCCP Cancer Genetic Counseling Assessment Tool: How to Assess Your Program and Improve Performance (Melanie Moshier, Jennifer N. Eichmeyer, Patricia D. Hegedus, et al.) Oncology Issues (2013)

An Assessment of Risk Understanding in Hispanic Genetic Counseling Patients (Jennifer N. Eichmeyer, Hope Northrup, Michael A. Assel, et al.) Journal of Genetic Counseling (2005)

This study sought to identify if differences existed in risk comprehension and risk format understanding between genetic counseling patients of Hispanic and Caucasian ethnicity. A total of 107 questionnaires were collected, 56 from Hispanic patients, ...

Rapid Communication: Genetic Linkage and Physical Mapping of the Porcine Androgen Receptor (AR) Gene (J. N. Seifert, N. J. Larsen, S. Marklund, et al.) Journal of Animal Science (1999)

Source and Description of Primers. Primers were designed from published bovine and human androgen receptor (AR) sequences (GenBank accession number Z75315 and M27430, respectively). These primers were used to obtain a porcine sequence (submitted to ...

Development and Initial Assessment of a Pharmacogenetics Education Module for Genetic Counseling Students (Rachel Mills, Jennifer Eichmeyer, Kristin Maloney, et al.) Clinical Pharmacogenetics Implementation Consortium (CPIC) Open Meeting 2019 (2019)

Integrating Introductory Genetics and Genomics Curriculum in an Adult Gerontology Nurse Practitioner Program (Jennifer N. Eichmeyer, R. Walters and J. Stock) ANA Idaho LEAP Conference (2019)

Development and Initial Assessment of a Pharmacogenetics Education Module for Genetic Counseling Students (Rachel Mills, Jennifer N. Eichmeyer, K. Maloney, et al.) 37th Annual Conference of the National Society of Genetic Counselors (2018)

Development and Initial Assessment of a Pharmacogenetics Education Module for Genetic Counseling Students (R. Mills, Jennifer N. Eichmeyer, K. Maloney, et al.) Duke AHEAD Health Professionals Education Day (2018)

Challenges and Opportunities in Bringing Genomic Testing into the Community Oncology Setting (Jennifer N. Eichmeyer and J. S. Biggerstaff) 2017 ACMG Annual Clinical Genetics Meeting (2017)

A Pilot Program for Genetic Test Utilization Management in a Community Hospital Setting (Jennifer N. Eichmeyer, E. Williams, J. S. Biggerstaff, et al.) PLUGS Summit (2017)

Facing the Challenge of Genetic Counselors’ Need for Education about Genomic Technologies: Opportunities for Improvement in Training for Genetic Counselors (K. Banks, D. Lamb Thrush, D. Dorsainville, et al.) 35th Annual Education Conference of the National Society of Genetic Counselors (2016)

Implementing Lynch Syndrome Screening Utilizing a Community Partnership (Jennifer N. Eichmeyer, M. Burtelow, M. Carey, et al.) 2013 ASCO Quality Care Symposium (2013)

Improving Oncofertility (S. Darland, Jennifer N. Eichmeyer, K. Christaens, et al.) 2013 ASCO's Quality Care Symposium (2013)

Telehealth for Oncology Genetic Counseling: An Idaho Experience (Jennifer N. Eichmeyer, D. S. Zuckerman, T. M. Beck, et al.) 2013 St. Luke's Research Symposium (2013)

The Value of a Genetic Counselor for Patient Identification (Jennifer N. Eichmeyer, D. S. Zuckerman, T. M. Beck, et al.) 2013 ACMG Annual Clinical Genetics Meeting (2013)